Taiwan Biomaterial Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 41.67 million compared to TWD 18.08 million a year ago. Net loss was TWD 47.44 million compared to TWD 55.37 million a year ago.

Basic loss per share from continuing operations was TWD 1.44 compared to TWD 1.68 a year ago. Diluted loss per share from continuing operations was TWD 1.44 compared to TWD 1.68 a year ago.